Our news

  • In August 2021 we learned that our National Institute for Health Research (NIHR) funding will cease in March 2023. We are grateful to have benefitted from many years of stable funding from NIHR for the Cochrane Airways editorial team, based at St George’s University of London, who support the production of Cochrane Airways Reviews. We are...
    September 21 2021
  • Authors from the Netherlands and Canada have written a review on Non‐invasive ventilation (ventilators) used at night by people with COPD. The lead author, Tim Raveling, said “This review investigated if chronic non-invasive ventilation (NIV) is effective compared to standard care for patients with severe chronic obstructive pulmonary disease (...
    August 18 2021
  • Do telehealth technologies help improve the health of people who have COPD?For the full review click here.BackgroundChronic obstructive pulmonary disease (COPD) includes a group of lung conditions that cause breathing difficulties. Symptoms include shortness of breath (dyspnoea), coughing, and increased mucus. COPD causes limited airflow in the...
    July 21 2021
  • A team of authors based in Australia updated the Cochrane Review on Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma. Lead author Zoe Kopsaftis said "People with asthma often experience symptoms of gastro-oesophageal reflux disease (GORD), which may prompt an exacerbation...
    May 18 2021
  • To celebrate World Asthma Day 2021 we launch a new review comparing combination fast-acting beta-agonist and steroid inhaler as required with either regular inhaled steroids or fast-acting beta-agonists as required alone in adults or children with mild asthma. Read more about it in this interview with one of the lead authors, Tim Hinks, based at...
    May 5 2021
  • An international team of researchers from London, Anne Arbour and Melbourne have published a review on digital interventions for COPD. Author Rebecca Disler said "Evidence on digital interventions for COPD management was inconclusive. High heterogeneity and lack of detailed reporting calls for standardized efficacy testing and understanding...
    April 20 2021
  • Orlagh O'Shea, who is an ESI fellow, published a new review with Chris Cates and Liz Stovold from the Cochrane Airways Editroial base team. Orlagh said that the take-home message from the review is "As long as salmeterol or formoterol are in a combined inhaler with an inhaled steroid we did not identify any safety issues which would affect the...
    April 14 2021
  • Review authors wanted to know if exercise training improves exercise tolerance, quality of life, or symptoms, and if it reduces the number of future flare-ups ('exacerbations'), for people with bronchiectasis compared to people who did not do exercise training. They looked at studies involving adults and children with stable disease and patients...
    April 1 2021
  • Pulmonary arterial hypertension is a devastating disease that leads to right heart failure and premature death. Endothelin receptor antagonists are a class of strong vasodilators (medications that open (dilate) blood vessels) capable of stopping the process of cell division, which could dilate and result in a favourable pulmonary arterial...
    March 29 2021
  • How does using technology to deliver pulmonary rehabilitation (PR) compare to centre‐based PR, or no PR in people with chronic lung disease?Bottom lineThis review suggests that primary pulmonary rehabilitation, or maintenance rehabilitation, delivered via telerehabilitation for people with chronic respiratory disease achieves outcomes similar to...
    February 2 2021

Pages

Subscribe to Our news